Procainamide

Revision as of 21:37, 18 November 2011 by Rossdonaldson1 (talk | contribs) (Created page with "== Adult Dosing == *Continuous infusion rate has fewer adverse effects **20-50mg/min for 25-30min ***Cont until arrhythmia is suppressed, hypotension, QRS >50% or max dose (17mg/...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Adult Dosing

  • Continuous infusion rate has fewer adverse effects
    • 20-50mg/min for 25-30min
      • Cont until arrhythmia is suppressed, hypotension, QRS >50% or max dose (17mg/kg)
      • If effective start cont infusion of 1-4mg/min

Contraindications

  • Not recommended for V-fib or pulseless V-tach (too long to dose)
  • 2nd or 3rd AV block
  • Severe glycoside intoxication
  • Prolonged QT
  • Myasthenia gravis

Indications

  • Wide-complex tachycardia of unknown type (in pts w/ preserved LV function)
  • Stable V-tach

Mechanism of Action

  • Class Ia
    • Binds to fast Na channels in inactive state thereby inhibiting recovery after repolarization
    • Prolongs action potential and reduces speed of impulse conduction
      • Depresses myocardial conduction
    • May act as negative inotrope, cause hypotension (peripheral vasodilation)

Adverse Drug Rxns

  • Myocardial depression
  • Watch for QRS/QT prolongation, V-tach, Vfib, complete AV block, torsades

Kinetics

  • Onset of action = 5-10min

See Also

  • Antiarrythmics